![Tomas Kiselak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 36 M $ al 30/09/2026
Mr. Tomas Kiselak is an Independent Director at Jade Biosciences, Inc., a Chairman at Korsana Biosciences, Inc., an Independent Director at Spyre Therapeutics, Inc., an Independent Chairman at Viridian Therapeutics, Inc., a Co-Manager at Viridian LLC and a Managing Member at Fairmount Funds Management LLC.
He is on the Board of Directors at Jade Biosciences, Inc., Jade Biosciences, Inc. (United States) and Spyre Therapeutics, Inc. Mr. Kiselak was previously employed as an Independent Director by Dianthus Therapeutics, Inc., an Independent Director by Apogee Therapeutics, Inc., an Independent Director by Zenas BioPharma, Inc., a Laboratory Assistant by Harvard Medical School, a Managing Director by RA Capital Management LP, and a Managing Director by RA Capital Management LP (Private Equity).
He also served on the board at Viridian Therapeutics, Inc. /Old/.
He received his undergraduate degree from Amherst College.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SPYRE THERAPEUTICS, INC 0,44 % | 07/10/2026 | 406.038 ( 0,44 % ) | 36 M $ | 30/09/2026 |
-.--% | 12/03/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
| 01/07/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Presidente | 01/06/2021 |
| SPYRE THERAPEUTICS, INC. | Director/Miembro de la Junta | 22/06/2023 |
| JADE BIOSCIENCES, INC. | Director/Miembro de la Junta | 28/04/2025 |
Fairmount Funds Management LLC
 Fairmount Funds Management LLC Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | - |
Viridian LLC
 Viridian LLC BiotechnologyHealth Technology Operates as a biopharmaceutical incubator company | Fundador | 01/01/2016 |
| Empresas | Cargo | Fin |
|---|---|---|
| APOE THERPAR | Director/Miembro de la Junta | 03/09/2026 |
| DIANTHUS THERAPEUTICS, INC. | Director/Miembro de la Junta | 04/03/2025 |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Inversor de Capital Privado | - |
Viridian Therapeutics, Inc. /Old/
 Viridian Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization. | Finance |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fairmount Funds Management LLC
Fairmount Funds Management LLC Investment ManagersFinance Provides investment advice | Finance |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Viridian LLC
Viridian LLC BiotechnologyHealth Technology Operates as a biopharmaceutical incubator company | Health Technology |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Finance |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Viridian Therapeutics, Inc. /Old/
Viridian Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Apogee Therapeutics, Inc.
 Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
Dianthus Therapeutics, Inc.
 Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
